Concern about completing clinical trials has led to questions about whether expanded access might be a better path than emergency authorization for COVID-19 vaccines. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
